ArriVent BioPharma, led by Bing Yao, licenses ADC MRG007 from Lepu Biopharma for $47M upfront, adding the drug to a portfolio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback